MPIC: Molecular Prognostic Indicators in Cirrhosis Database for Clinical Context-Specific in Silico Prognostic Biomarker Validation

Prognostic biomarkers are vital in the management of progressive chronic diseases such as liver cirrhosis, affecting 1–2% of the global population and causing over 1 million deaths every year. Despite numerous candidate biomarkers in literature, the costly and lengthy process of validation hampers t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Shun H., Fujiwara, Naoto, Burke, Jason, Shetler, Anand, Peralta, Celina, Qian, Tongqi, Hoshida, Hiroki, Zhu, Shijia, Hoshida, Yujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759478/
https://www.ncbi.nlm.nih.gov/pubmed/31620162
http://dx.doi.org/10.3389/fgene.2019.00830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759478/
https://www.ncbi.nlm.nih.gov/pubmed/31620162
http://dx.doi.org/10.3389/fgene.2019.00830

Ejemplares similares